CANCER BUZZ PODCAST

In this episode, CANCER BUZZ speaks with Jeff Sharman, MD about the role of biomarker testing in guiding treatment decisions and how evidence-based management of treatment-related adverse events can serve this patient population.

In this episode, CANCER BUZZ speaks with Jeff Sharman, MD about the role of biomarker testing in guiding treatment decisions and how evidence-based management of treatment-related adverse events can serve this patient population.

In this episode, CANCER BUZZ speaks with Nirav Shah, MD, MSHP and Kirollos Hanna, PharmD, BCOP, PCOP, FACCC about shared decision making in the management of relapsed or refractory mantle cell lymphoma.

In this episode, CANCER BUZZ speaks with Karen Fancher, PharmD, BCOP, and Victoria Nachar, PharmD, BCOP, about strategies to address common adverse events experienced by patients with mantle cell lymphoma. 

In this episode, CANCER BUZZ speaks with Jean Louise Koff, MD, MSc, associate professor at Emory University School of Medicine in Atlanta, Georgia, about fostering trust, rapport, and collaboration in the patient-provider relationship.

In this episode, CANCER BUZZ speaks with David Sallman, MD and Karley Trautman, DNP, ANP-BC, AGACNP-BC, to discuss best practices in the management of anemia in low-risk MDS patients.

Anemia presents a significant challenge in the management of patients with low-risk MDS. As clinicians focus on maintaining quality of life, it is necessary to understand the care sequencing of anemia treatment in patients with low-risk MDS.

In this episode, CANCER BUZZ speaks with Courtney VanHouzen, PharmD.

This discussion elucidates an array of patient-centered approaches, touches on social determinants of health, and highlights collaborative measures to support care coordination in the management of anemia in patients with high-risk MDS and AML

Improving timely identification and referral of patients who may be eligible for chimeric antigen receptor (CAR) T-cell therapy is critical for improving outcomes for patients with hematologic malignancies.

CANCER BUZZ speaks with Aaron Cumpston, PharmD, and Christine Barrett, PharmD, BCOP, who discuss the challenges of care coordination and therapy and share operational best practices for the delivery of bispecific antibodies in the community setting.

In this episode, CANCER BUZZ speaks with Linda Hayward, patient financial advocate at the University of Maryland, Kaufman Cancer Center at Upper Chesapeake Health

CANCER BUZZ spoke to Robin Atkins, RN, OCN, symptom triage nurse, Virginia Oncology Associates in Norfolk, Virginia. Listen as we discuss effective practices to support patients with diffuse large b-cell lymphoma throughout the care continuum.

In this episode, CANCER BUZZ speaks with David L. Porter, MD, director of Cell Therapy and Transplant at Penn Medicine.

Coordination of care for patients diagnosed with acute myeloid leukemia, particularly those who are ineligible for transplant, can impact access to specialist care, clinical trials, and cancer programs with advanced capabilities to treat patients.

CANCER BUZZ speaks with Farrukh T. Awan, MD, MS about an approach to addressing regional barriers to improve care for patients with chronic lymphocytic leukemia.

CANCER BUZZ speaks with Melissa Kah Poh Loh, MBBCh, BAO, assistant professor of Geriatric Hematology and Oncology about strategies to optimize critical conversations with patients with acute myeloid leukemia.

In this episode, CANCER BUZZ speaks about strategies to address these disparities and optimize care and treatment options for patients with acute myeloid leukemia who do not receive a transplant.

As myeloproliferative neoplasms (MPNs) carry a heavy symptom burden which can significantly impact a patient’s quality of life, hear how multidisciplinary care and psycho-social support can help alleviate this burden for patients.